Earnings Outlook For CymaBay Therapeutics
Portfolio Pulse from Benzinga Insights
CymaBay Therapeutics (NASDAQ:CBAY) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.30. The company's past performance shows a trend of beating EPS estimates, which has often resulted in an increase in share price. The company's shares were trading at $16.36 as of November 3, and have seen a 371.33% increase over the last 52-week period.
November 06, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CymaBay Therapeutics is expected to release its Q3 earnings report. Given the company's history of beating EPS estimates and the subsequent positive impact on its share price, this could potentially influence the stock's performance.
CymaBay Therapeutics has a history of beating EPS estimates, which has often resulted in an increase in its share price. Given this trend, the upcoming earnings report could potentially have a positive impact on the stock's performance. However, it's important to note that other factors, such as the company's guidance for the next quarter, could also influence the stock's performance.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100